Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Remepy Partners with Merck to Develop Hybrid Drugs Across Therapeutic Areas
Wednesday, April 29, 2026Remepy has entered into a collaboration with Merck to advance the development of hybrid drugs across multiple therapeutic areashe initial phase of the partnership will focus on selected programmes in the United States particularly in a rare tumour se...
Gilead Acquires Arcellx to Strengthen Cancer Treatment Pipeline
Wednesday, April 29, 2026Gilead Sciences has completed its acquisition of Arcellx in a deal valued at approximately billion Anitocel is a BCMAdirected CAR Tcell therapy that uses a Ddomain binder This design aims to improve CAR expression while reducing unwanted immune acti...
Taiho Oncology Announces FDA Acceptance of Zipalertinib Application for Advanced Lung Cancer
Wednesday, April 29, 2026Taiho Oncology along with Taiho Pharmaceutical and Cullinan Therapeutics has announced that the US Food and Drug Administration FDA has accepted a New Drug Application NDA for zipalertinib
Lilly to Acquire Ajax Therapeutics to Advance Treatments for Myelofibrosis and Polycythaemia Vera
Tuesday, April 28, 2026Eli Lilly and Company has entered into a definitive agreement to acquire Ajax Therapeutics Ajaxs lead candidate AJ is an investigational oncedaily oral Type II JAK inhibitor It is currently being evaluated in a Phase clinical trial
Terns Pharmaceuticals Receives Breakthrough Therapy for TERN-701 in Chronic Myeloid Leukemia (CML)
Tuesday, April 28, 2026Terns Pharmaceuticals has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation BTD to TERN an investigational oral allosteric BCRABL inhibitor
Cipla Secures US FDA Approval for First AB-Rated Generic of Ventolin HFA
Friday, April 24, 2026Cipla and its subsidiary Cipla USA have received final approval from the US Food and Drug Administration FDA for their Abbreviated New Drug Application ANDA for Albuterol Sulfate Inhalation Aerosol mcg per actuation The product is the first ABrated...
AbbVie to Invest $1.4 Billion in New Manufacturing Campus in North Carolina
Thursday, April 23, 2026AbbVie has announced plans to invest billion in the development of a pharmaceutical manufacturing campus in Durham North Carolina The acre site will incorporate advanced manufacturing systems
Leinco Technologies and CellCarta Partner to Strengthen Proteomics Solutions for Drug Development
Wednesday, April 22, 2026Leinco Technologies a specialist in antibody and protein development has entered into a strategic collaboration with CellCarta a global provider of precision medicine laboratory services to advance proteomics
New combination therapy for advanced small cell lung cancer approved in Australia and Singapore
Tuesday, April 21, 2026Independent biopharmaceutical company Specialised Therapeutics has secured approval for ZEPZELCA lurbinectedin in combination with atezolizumab as a firstline maintenance treatment for adults with extensivestage
Biogen Inc. to invest in felzartamab rights in Greater China through agreement with TJ Biopharma
Tuesday, April 21, 2026Biogen Inc has entered into a definitive agreement to invest in the exclusive rights to felzartamab held by TJ Biopharma in the Greater China region Following the agreement Biogen will hold exclusive global rights to the drug candidate which is curre...
